Levalbuterol <i>vs.</i> albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levalbuterol vs. albuterol for hospitalized patients with COPD in China: cost-utility and budget impact analysis

Published:2022-07-29 Issue:1 Volume:25 Page:966-973
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Chen Lei¹^ORCID,Chen Xianqiu²^ORCID,Zhi Canghong³,Li Xuan³,Hu Yang²^ORCID

Affiliation:

1. School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China

2. Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China

3. Joincare Pharmaceutical Group Industry Co. Ltd., Shenzhen, China

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2096892

Reference37 articles.

1. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

2. Trends in Outcomes, Financial Burden, and Mortality for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010

3. Disease burden of COPD in China: a systematic review

4. Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality

5. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparity of the Treatment of Unresectable Non-small Cell Lung Cancer Regarding Chemotherapy: A Systematic Review and Meta-Analysis;Cureus;2024-05-19

2. Estimating the Economic Impact of Levalbuterol’s Potential Transition From the National Reimbursement Drug List for the Treatment of Pediatric Asthma in China: A Budget Impact Analysis;Cureus;2024-05-19

3. Quantifying the Length of Stay and Economic Impact of Albuterol and Levalbuterol in Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study;Cureus;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3